Human fascioliasis by Fasciola hepatica: The first case report in Nepal

被引：12

作者：

Sah R. ^{[1
]}

Khadka S. ^{[1
]}

Khadka M. ^{[2
]}

Gurubacharya D. ^{[2
]}

Sherchand J.B. ^{[1
]}

Parajuli K. ^{[1
]}

Shah N.P. ^{[1
]}

Kattel H.P. ^{[1
]}

Pokharel B.M. ^{[1
]}

Rijal B. ^{[1
]}

机构：

[1] Department of Microbiology, Institute of Medicine, Tribhuvan University and Teaching Hospital (TUTH), Kathmandu

[2] Department of Medicine (Gastroenterology), Institute of Medicine, Tribhuvan University and Teaching Hospital (TUTH), Kathmandu

来源：

BMC Research Notes | / 10卷 / 1期

关键词：

Fasciola hepatica; Fascioliasis; Nepal; Right hypochondriac pain; TUTH (Tribhuvan University Teaching Hospital);

D O I：

10.1186/s13104-017-2761-z

中图分类号：

学科分类号：

摘要：

Background: Fascioliasis is a zoonotic disease caused by Fasciola species. Patient may be asymptomatic or presents with jaundice and biliary colic or right hypochondriac pain due to bile duct obstruction with gastrointestinal symptoms. Case presentation: We report a case of human fascioliasis in a 45 years old female presented to Tribhuvan University Teaching Hospital (TUTH), Kathmandu, Nepal on August, 2015 with fever, right hypochondriac pain, jaundice and occasional vomiting with anorexia for 4 months whose alkaline phosphatase was elevated and peripheral blood smear revealed eosinophilia. The patient also gives the history of consumption of water-cress. Endoscopic Retrograde Cholagiopancretography (ERCP) showed the presence of a flat worm resembling Fasciola hepatica and stool routine examination revealed ova of F. hepatica. The patient was treated with nitazoxanide by which she got improved. Repeat stool examination 2 weeks after treatment revealed no ova of F. hepatica. Conclusions: Patient with fascioliasis can be simply diagnosed with stool routine microscopy and treated with nitazoxanide. So patient with right hypochondriac pain, sign and symptoms of obstructive jaundice, eosinophilia and history of water-cress consumption should be suspected for fascioliasis and investigated and treated accordingly. © 2017 The Author(s).

引用

共 11 条

[1] Goral V., Senturk S., Mete O., Cicek M., Ebik B., Kaya B., A case of biliary fascioliasis by Fasciola gigantica in Turkey, Korean J Parasitol, 49, 1, pp. 65-68, (2011)
[2] Chatterjee K.D., Parasitology (Protozoology and Helminthology), pp. 186-188, (2014)
[3] Arora D.R., Arora B.B., Medical Parasitology, pp. 158-160, (2010)
[4] Mackie T.J., McCartney J.E., Practical Medical Microbiology, (2006)
[5] Marcilla A., Barques M.D., Mas-Coma S., A PCR-RFLP assay for the distinction between Fasciola hepatica and Fasciola gigantica, Mol Cell Probes, 16, 5, pp. 327-333, (2002)
[6] Jones E.A., Kay J.M., Milligan H.P., Owens D., Massive infection with Fasciola hepatica in man, Am J Med, 63, (1977)
[7] Santiago N., Hillyer G.V., Antibody profiles by EITB and ELISA of cattle and sheep infected with Fasciola hepatica, J Parasitol, 74, (1988)
[8] McManus D.P., Dalton J.P., Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica, Parasitology., 133, pp. S43-S61, (2006)
[9] Soliman M.F.M., Epidemiological review of human and animal fascioliasis in Egypt, J Infect Dev Ctries, 2, 3, pp. 182-189, (2008)
[10] Mas-Coma M.S., Esteban J.G., Bargues M.D., Epidemiology of human fascioliasis: A review and proposed new classification, Bull World Health Organ, 77, 4, pp. 340-346, (1999)

← 1 2 →